Good clinical data management practice

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Good clinical data management practice" – news · newspapers · books · scholar · JSTOR (January 2021) (Learn how and when to remove this message)

|

Good clinical data management practice (GCDMP) is the current industry standards for clinical data management that consist of best business practice and acceptable regulatory standards. In all phases of clinical trials, clinical and laboratory information must be collected and converted to digital form for analysis and reporting purposes. The U.S. Food and Drug Administration[1][2] and International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use have provided specific regulations and guidelines surrounding this component of the drug and device development process. The effective, efficient and regulatory-compliant management of clinical trial data is an essential component of drug and device development.

The Society for Clinical Data Management (SCDM)[3] has created the Good Clinical Data Management Practices (GCDMP©) standard,[4] a comprehensive document that provides guidance on accepted practices of clinical data management (CDM) that are not totally covered by current guidelines and regulations. This document is updated by Subject Matter Experts on a continuous basis.

## See also

[edit]

* Center for Biologics Evaluation and Research (CBER)
* Center for Drug Evaluation and Research (CDER)
* Center for Devices and Radiological Health (CDRH)
* Center for Food Safety and Nutrition (CFSAN)
* Center for Veterinary Medicine (CVM)
* Good clinical practice
* GxP
* Office of Regulatory Affairs (ORA)
* U.S. Department of Health and Human Services

## References

[edit]

1. ^ "Guidance for Industry Computerized Systems Used in Clinical Investigations". fda.gov. Archived from the original on 16 May 2024. Retrieved 4 July 2024.
2. ^ "Guidance for Industry Part 11, Electronic Records; Electronic Signatures — Scope and Application". fda.gov. Archived from the original on 18 March 2024. Retrieved 4 July 2024.
3. ^ "Home". Society for Clinical Data Management (SCDM). May 22, 2024. Archived from the original on October 17, 2020. Retrieved October 12, 2020.
4. ^ "GCDMP©". Archived from the original on 2020-10-12. Retrieved 2020-10-12.

## External links

[edit]

* Title 21 Code of Federal Regulations (21 CFR Part 11), Electronic Records; Electronic Signatures, Final Rule Published in the Federal Register